A new “tariff deal” between the United States and China may have cooled trade tensions — but it’s igniting fresh challenges inside America’s healthcare system. As tariffs on medical devices and pharmaceuticals remain in place, hospitals face rising costs, and seniors could soon pay more for prescriptions and essential care. This in-depth analysis explores how shifting America tariffs and the current tariff status threaten to reshape the economics of elder care, drug access, and the future of U.S. health innovation.
